PATENT CLAIM ANALYSIS

Application Number: 15949902
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods and compositions for increasing production of a target protein or functional RNA by a cell.

Claim (Index 88):
The method of  claim 72 , wherein the antisense oligomer is administered to the human subject by intravitreal injection, intrathecal injection, intraperitoneal injection, subcutaneous injection, intravenous injection, subretinal injection, intracerebroventricular injection, intramuscular injection, topical application, or implantation.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.05263
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14874420', '14647952', '14897698', '13093958', '14134057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7448586649609013
- 35 USC 102 Novelty (BERT): 0.7254113966207894
- Combined Prediction Score: 0.7429139381268901
- Mean Citation Score: 450.711916
- Max Citation Score: 893.8491
- Similarity Product: 767.2442534982562

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test